BIO President and CEO Jim Greenwood to Chair BIO Ventures for Global Health Board of Directors
BIO Ventures for Global Health (BVGH) today announced that Jim Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO) has been elected as the new BVGH Board Chair for a term of three years. Click here to read more.
Institut Pasteur joins WIPO Re:Search as 101st Member
WIPO Re:Search has now surpassed 100 members and is just shy of 100 agreements to share intellectual property in the fight against neglected tropical diseases, tuberculosis and malaria - both significant milestones for the consortium as it heads into its fifth full year of operation. Click here to read more.
BVGH, Agilent Technologies, and Merck collaborate to build capacity in Africa to fight NTDs
As a part of its Fellowship Program, BVGH sent a gently-used Agilent high-performance liquid chromatography (HPLC) system, alongside two Merck scientists, to the University of Buea in Cameroon. To read more about this instrument placement and fellowship, click here.
BVGH Accelerates R&D for Neglected Diseases through WIPO Re:Search Collaborations
BVGH released its second compilation of WIPO Re:Search collaboration stories featuring partnerships accelerating neglected disease research. The report highlights 26 specific, successful product development collaborations. Click here to read the storybook.
BVGH President, Jennifer Dent, Discusses Financial and Economic Strengths of Nigeria for the Pharmaceutical Market with PharmaVOICE
Jennifer Dent, President of BVGH, was recently interviewed by PharmaVOICE Magazine in "Balancing Risk and Reward in Nigeria", regarding the country's potential as an up-and-coming pharmaceutical market. Click here to read more.